InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,011.12
(
-0.22%
)
US TECH 100
16,883.20
(
-0.31%
)
Dow Jones
37,775.38
(
0.00%
)
Brent Oil
86.00
(
-0.48%
)
Bitcoin
65,080.00
(
2.46%
)
Post# of 29
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

xr_biotech_consult

Send PM Follow Ignore
Followers 16
Posts 1145
Boards Moderated 0
Alias Born 03/12/2010

xr_biotech_consult

Re: None

Friday, 03/11/2016 12:25:22 PM

Friday, March 11, 2016 12:25:22 PM

Post# of 29
pivotal Phase 3 trail completed, top line results expected q2, fast track by FDA, rare desease, Long patent protection, Peak sales expected -1b ! ongoing Pipeline with rare deseases.. still great opportunity here
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent BLU News
More BLU News
InvestorsHub NewsWire

Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM

ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM

Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM

Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM

Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM

Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!